StockNews.com started coverage on shares of Grifols (NASDAQ:GRFS – Get Rating) in a research report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. GRFS has been the topic of a number of other reports. Barclays upgraded shares of Grifols from an underweight rating to an equal weight rating in […]